BioMarin Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
05.09.24
/
50%
€75.46
Target price
05.09.25
€108.11
Performance (%)
-34.85%
End price
06.09.25
€49.16
Summary
This prediction ended on 06.09.25 with a price of €49.16. The BUY prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc. performed very badly with a performance of -34.85%. JPMorgan_Chase___Co_ has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 1.335% | 1.335% | -27.517% |
| iShares Core DAX® | 0.751% | -8.496% | 2.575% |
| iShares Nasdaq 100 | -1.405% | -2.771% | 15.682% |
| iShares Nikkei 225® | 0.417% | -9.291% | 29.655% |
| iShares S&P 500 | -0.590% | -2.868% | 9.963% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at JPMorgan Chase & Co. from $111.00 to $120.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.32
14.07.25
14.07.25
€96.68
14.07.26
14.07.26
-4.99%
30.03.26
30.03.26
Stopped prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.83
09.10.25
09.10.25
€102.23
09.10.26
09.10.26
2.09%
30.03.26
30.03.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€61.40
30.10.24
30.10.24
€100.36
30.10.25
30.10.25
-26.91%
31.10.25
31.10.25